Revised SPC: VFEND (voriconazole) products

SPC has been updated to warn voriconazole is expected to significantly increase naloxegol concentrations, therefore coadministration is not recommended, and also that reversible cases of adrenal insufficiency have been reported in patients receiving voriconazole.

electronic Medicines compendium